Reuters logo
BRIEF-Vectura signs VR410 agreement with Pulmatrix
September 6, 2017 / 6:29 AM / in 3 months

BRIEF-Vectura signs VR410 agreement with Pulmatrix

Sept 6 (Reuters) - Vectura Group Plc

* VECTURA ANNOUNCES VR410 AGREEMENT WITH PULMATRIX

* PROGRESSING DEVELOPMENT OF BRANDED GENERIC TIOTROPIUM BROMIDE PROGRAMME (VR410) FOR US MARKET, ACCELERATED THROUGH LICENCE DEAL WITH PULMATRIX

* DOES NOT EXPECT A MATERIAL IMPACT ON R&D EXPENDITURE FOR FEASIBILITY STUDY AND EARLY DEVELOPMENT PRIOR TO LICENSING Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below